You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine tumors (NET)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Recruiting
  • Neuroendocrine Tumors (NET)
  • 68Ga-HA-DOTATATE PET/CT imaging
  • Calgary, Alberta, Canada
    Foothills Medical Center 1403 29 St NW
Jan 4, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Collect Somatuline® Injector Device Preferences of Patients

Not yet recruiting
  • Neuroendocrine Tumors
    • (no location specified)
    Jun 19, 2023

    Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

    Completed
    • Neuroendocrine Tumors
    • +3 more
    • Amino Acid Based Medical Food/Drink
    • Lexington, Kentucky
      University of Kentucky Markey Cancer Center
    Nov 2, 2022

    Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Gastroenteropancreatico Tumors
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

    Not yet recruiting
    • Neuroendocrine Tumors
    • +8 more
    • Iowa City, Iowa
    • +1 more
    Nov 23, 2022

    Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

    Enrolling by invitation
    • Neuroendocrine Tumor Grade 2
    • Neuroendocrine Tumor Grade 1
    • Iowa City, Iowa
      The University of Iowa
    Dec 9, 2022

    GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

    Enrolling by invitation
    • GEP-NET
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    Jan 24, 2023

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

    Recruiting
    • Neuroendocrine Tumor Carcinoid
    • +2 more
      • Milan, Italy
        IRCCS Istituto Europeo di Oncologia S.r.l.
      Jul 8, 2022

      Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

      Not yet recruiting
      • Small Cell Lung Cancer (SCLC)
      • +3 more
      • (no location specified)
      Dec 7, 2022

      Quality of Life and Tolerance of Patients Treated With

      Not yet recruiting
      • Metastatic Neuroendocrine Tumour
        • Lyon, France
          Hospices Civils de Lyon, Hopital Lyon Sud
        Sep 12, 2023

        DOTATOC PET/CT for Imaging NET Patients

        Recruiting
        • Neuroendocrine Tumors
        • +15 more
        • 68Ga-DOTATOC PET/CT
        • 18F-FDG PET/CT
        • Vancouver, British Columbia, Canada
          BC Cancer
        Nov 2, 2022

        Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

        Recruiting
        • Neuroendocrine Tumours (NET)
        • Neuroendocrine Carcinomas (NEC)
        • Santiago De Compostela, Galicia, Spain
        • +4 more
        Aug 1, 2022

        GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

        Recruiting
        • GEP-NET
        • +6 more
        • Duarte, California
        • +3 more
        Jul 28, 2022

        Preoperative Imaging in Small Bowel Neuroendocrine Tumors

        Recruiting
        • Neuroendocrine Tumors
        • +2 more
        • preoperative imaging
        • Nancy, France
        • +1 more
        Feb 9, 2022

        Lutathera® in Somatostatin Receptor Positive

        Recruiting
        • Somatostatin Receptor-positive GEP-NET
        • Lutathera
        • Seongnam Si, Gyeonggi Do, Korea, Republic of
        • +4 more
        Jun 29, 2022

        Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

        Not yet recruiting
        • Neuroendocrine Tumor (NET)
        • Colorectal Cancer (CRC)
        • CHM-2101 CAR-T cells
        • (no location specified)
        Sep 20, 2023

        Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

        Recruiting
        • Neuroendocrine Tumor Grade 2
        • Neuroendocrine Tumors
        • Capecitabine Oral Product
        • +2 more
        • Little Rock, Arkansas
        • +2 more
        Aug 11, 2022

        Neuroendocrine Tumors - Patient Reported Outcomes

        Enrolling by invitation
        • Neuroendocrine Tumors
        • +3 more
          • Gainesville, Florida
          • +13 more
          Jul 7, 2022

          Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

          Withdrawn
          • Neuroendocrine Tumors
          • +2 more
          • Telotristat ethyl
          • +2 more
          • Iowa City, Iowa
            University of Iowa Hospital and Clinics
          Feb 9, 2022

          Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

          Suspended
          • Gastroenteropancreatic Neuroendocrine Tumor
          • Stanford, California
            Stanford Cancer Institute Palo Alto
          Sep 21, 2022

          Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

          Active, not recruiting
          • Neuroendocrine Tumors
          • Oxaliplatin-based chemotherapy
          • Alkylating-based chemotherapy
          • Amiens, France
          • +18 more
          Mar 15, 2022

          Quality of Life Trial in Belgium (EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey)

          Recruiting
          • Quality of Life
          • EORTC QLQ-C30
          • +2 more
          • Brasschaat, Antwerp, Belgium
          • +6 more
          Mar 8, 2022